News

  • USDA and AUM LifeTech develop a novel Non-GMO RNA silencing approach against citrus greening for bacteria, insect and pathogen control. The data will be presented at the upcoming International Plant & Animal Genome XXV conference, in San Diego, California in January of 2017.

    November 16

  • AUM's next generation FANA RNA silencing technology was showcased in several studies at the 2016 Oligonucleotide Therapeutics Society Meeting. Multiple applications related to RNA silencing and regulation were demonstrated with a goal to advance biomedical research and therapeutic development.    

    October 16

  • AUM LifeTech with collaborators at the Beckman Research Institute at the City of Hope in California and McGill University in Canada has developed a new approach to combat HIV. Encouraging data showing the inhibition of HIV replication using AUM LifeTech's FANA antisense technology was presented at the 2016 annual Oligonucleotide Therapeutics Society meeting (OTS).  

    October 16

  • AUM LifeTech participates at JP Morgan’s 33rd Annual Healthcare Conference in San Francisco, USA. JP Morgan conference is one of the largest and most informative healthcare investment symposium in the industry, bringing together global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community

    January 15

  • AUM LifeTech participates at the BIO Europe Conference in Frankfurt, Germany

    November 14

  • AUM LifeTech participates at the 14th Annual Biotech in Europe Forum For Global Partnering & Investment in Basel, Switzerland

    September 14

  • AUM LifeTech participates at the BIO Convention in San Diego, USA.

    June 14

  • AUM LifeTech participates at the BioPharma ASIA convention in Singapore to explore potential strategic alliances in Asia.

    March 14

  • AUM LifeTech participates at the BIO CEO and Investor Conference in New York. The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

    February 14

  • AUM LifeTech participates at the ASIA Tides 2014 meeting in Tokyo, Japan.

    February 14

  • AUM LifeTech participates at the JP Morgan’s 32nd Annual Healthcare Conference. JPM is one of the largest and most informative healthcare investment symposium in the industry, bringing together global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community

    January 14

  • AUM LifeTech secures excusive license rights on the 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA) technology from McGill University, Canada.

    December 13

  • AUM LifeTech participates at the Extenda Meeting 2013 (a European Union supported organization) to facilitate business collaborations between Spain and the US. This meeting was co-organized by Extenda (the Trade & investment Agency of Andalucia), Andalucia Bioregion and Bioandalucia (The Andalusian Association of Biotech Companies).

    November 13

  • AUM LifeTech is nominated as the Life Sciences Startup Company of the year for the 2014 Enterprise Awards. The Enterprise Awards, presented by Greater Philadelphia Alliance for Capital and Technologies (PACT) in partnership with KPMG recognizes and honors leadership and outstanding achievement in the technology, health and life sciences, medtech and cleantech industries throughout the region.

    November 13